J Biomed Nanotechnol. 2014 Mar;10(3):367-82. doi: 10.1166/jbn.2014.1778.
Cancer has become one of the major reasons for disease mortality with drastic increase of death rate in recent years. The reason for most of these deaths is due to the inefficacy and failure of the current methods of treatments or due to the unavailability of treatment options. Even after extensive research that has been carried out in the field, there is no gold standard in cancer therapy. With the advancement of the field of nanomedicine and materials science, many research works are being aimed at developing micro and nanocarriers for site-specific delivery of anticancer drugs. As a further advancement in the field, smart carriers, based on nanobiomaterials, which respond to various external and internal stimuli and act locally are being developed to improve the efficacy of current treatments. These smart nanobiomaterials act as carriers for not only anticancer drugs but also for gene and other biomolecules. Keeping the importance and advancement of smart carrier anticancer drug delivery system (AcDDS) in view, this review focuses on stimuli responsive nanobiomaterials that are currently being studied for cancer therapy.
癌症已成为主要疾病致死原因之一,近年来死亡率急剧上升。造成这些死亡的大部分原因是当前治疗方法的无效和失败,或者是因为缺乏治疗选择。尽管在该领域进行了广泛的研究,但癌症治疗仍然没有金标准。随着纳米医学和材料科学领域的进步,许多研究工作旨在开发用于抗癌药物的靶向传递的微纳米载体。作为该领域的进一步发展,基于纳米生物材料的智能载体正在被开发,以响应各种外部和内部刺激并在局部起作用,从而提高现有治疗方法的疗效。这些智能纳米生物材料不仅可以作为抗癌药物的载体,还可以作为基因和其他生物分子的载体。考虑到智能载体抗癌药物输送系统(AcDDS)的重要性和进展,本综述重点介绍了目前正在研究用于癌症治疗的响应性纳米生物材料。